Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 36, Issue 1, 2017, Pages 95-104

  Lagunes, L ^a,b   Rey Perez A ^a   Martin Gomez M T ^a   Vena, A ^c   de Egea, V ^c   Munoz P ^c,d,e   Bouza, E ^c   Diaz Martin A ^f   Palacios Garcia I ^f   Garnacho Montero, J ^f   Campins, M ^a   Bassetti, M ^g   Rello, J ^b,e  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^g S Maria Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; CORTICOSTEROID; FLUCONAZOLE; HYPERTENSIVE AGENT; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; MICAFUNGIN; VASOACTIVE AGENT; VORICONAZOLE;

ABDOMINAL ABSCESS; ABDOMINAL INFECTION; ADULT; AGED; ANTIFUNGAL SUSCEPTIBILITY; ANTIFUNGAL THERAPY; ARTICLE; BILIARY TRACT INFECTION; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDIASIS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FUNGUS GROWTH; HEMATOLOGIC DISEASE; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; INTRAABDOMINAL CANDIDIASIS; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NEOPLASM; PATHOPHYSIOLOGY; PERITONITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEPTIC SHOCK; SPAIN; SURGICAL WARD; SURVIVAL RATE; UNIVERSITY HOSPITAL; ANIMAL; CARE BUNDLE; CLINICAL TRIAL; EPIDEMIOLOGY; INTENSIVE CARE; INTRAABDOMINAL INFECTIONS; PROCEDURES; SURVIVAL ANALYSIS;

ADULT; AGED; ANIMALS; CANDIDIASIS; CRITICAL CARE; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INTRAABDOMINAL INFECTIONS; MALE; MIDDLE AGED; PATIENT CARE BUNDLES; RETROSPECTIVE STUDIES; SPAIN; SURVIVAL ANALYSIS;

EID: 84988583467     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-016-2775-9     Document Type: Article

References (38)

1. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, EPIC II Group of Investigators (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323–2329
2. Montravers P, Dupont H, Gauzit R, Veber B, Auboyer C, Blin P, Hennequin C, Martin C (2006) Candida as a risk factor for mortality in peritonitis. Crit Care Med 34(3):646–652
3. Montravers P, Blot S, Dimopoulos G, Eckmann C, Eggimann P, Guirao X, Paiva JA, Sganga G, De Waele J (2016) Therapeutic management of peritonitis: a comprehensive guide for intensivists. Intensive Care Med 42(8):1234–1247
4. Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, Meersseman W, Akova M, Arendrup MC, Arikan-Akdagli S, Bille J, Castagnola E, Cuenca-Estrella M, Donnelly JP, Groll AH, Herbrecht R, Hope WW, Jensen HE, Lass-Flörl C, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Viscoli C, Ullmann AJ, ESCMID Fungal Infection Study Group (2012) ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microb Infect 18(Suppl 7):19–37
5. Bassetti M, Marchetti M, Chakrabarti A, Colizza S, Garnacho-Montero J, Kett DH, Munoz P, Cristini F, Andoniadou A, Viale P, Rocca GD, Roilides E, Sganga G, Walsh TJ, Tascini C, Tumbarello M, Menichetti F, Righi E, Eckmann C, Viscoli C, Shorr AF, Leroy O, Petrikos G, De Rosa FG (2013) A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med 39(12):2092–2106
6. Montravers P, Dupont H, Eggimann P (2013) Intra-abdominal candidiasis: the guidelines—forgotten non-candidemic invasive candidiasis. Intensive Care Med 39:2226–2230
7. León C, Ostrosky-Zeichner L, Schuster M (2014) What’s new in the clinical diagnostic management of invasive candidiasis in critically ill patients. Intensive Care Med 40(6):808–819
8. Schuijt T, van der Poll T, de Vos WM, Wiersinga WJ (2013) The intestinal microbiota and host immune interactions in the critically ill. Trends Microbiol 21(5):221–229
9. Ostrosky-Zeichner L, Sable C, Sobel J, Alexander BD, Donowitz G, Kan V, Kauffman CA, Kett D, Larsen RA, Morrison V, Nucci M, Pappas PG, Bradley ME, Major S, Zimmer L, Wallace D, Dismukes WE, Rex JH (2007) Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microb 26:271–276
10. Bassetti M, Righi E, Ansaldi F, Merelli M, Scarparo C, Antonelli M, Garnacho-Montero J, Diaz-Martin A, Palacios-Garcia I, Luzzati R, Rosin C, Lagunes L, Rello J, Almirante B, Scotton PG, Baldin G, Dimopoulos G, Nucci M, Munoz P, Vena A, Bouza E, de Egea V, Colombo AL, Tascini C, Menichetti F, Tagliaferri E, Brugnaro P, Sanguinetti M, Mesini A, Sganga G, Viscoli C, Tumbarello M (2015) A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med 41:1601–1610
11. Marshall JC, Maier RV, Jimenez M, Dellinger EP (2004) Source control in the management of severe sepsis and septic shock: an evidence-based review. Crit Care Med 32(Suppl):S513–S526
12. Knaus WA, Draper EA, Wagner DP, SImmerman JE (1985) APACHE II score: a severity of disease classification system. Crit Care Med 13:818–829
13. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R, Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39(2):165–228
14. Bader FG, Schröder M, Kujath P, Muhl E, Bruch HP, Eckmann C (2009) Diffuse postoperative peritonitis — value of diagnostic parameters and impact of early indication for relaparotomy. Eur J Med Res 14(11):491–496
15. Pieracci FM, Barie PS (2007) Intra-abdominal infections. Curr Opin Crit Care 13(4):440–449
16. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O’Neill PJ, Chow AW, Dellinger EP, Eachempati SR, Gorbach S, Hilfiker M, May AK, Nathens AB, Sawyer RG, Bartlett JG (2010) Diagnosis and management of complicated intra abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 50:133–164
17. Solomkin JS, Ristagno RL, Das AF, Cone JB, Wilson SE, Rotstein OD, Murphy BS, Severin KS, Bruss JB (2013) Source control review in clinical trials of anti-infective agents in complicated intra abdominal infections. Clin Infect Dis 56(12):1765–1773
18. Azuhata T, Kinoshita K, Kawano D, Komatsu T, Sakurai A, Chiba Y, Tanjho K (2014) Time from admission to initiation of surgery for source control is a critical determinant of survival in patients with gastrointestinal perforation with associated septic shock. Crit Care 18(3):R87
19. Sandven P, Qvist H, Skovlund E, Giercksky KE, NORGAS Group and the Norwegian Yeast Study Group (2002) Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. Crit Care Med 30(3):541–547
20. Dupont H, Paugam-Burtz C, Muller-Seryes C, Fierobe L, Chosidow D, Marmuse JP, Mantz J, Desmonts JM (2002) Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients. Arch Surg 137:1341–1346
21. Montravers P, Mira JP, Gangneux JP, Leroy O, Lortholary O, AmarCand study group (2011) A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive care units. Clin Microbiol Infect 17:1061–1067
22. Pappas P, Kauffman C, Andes D, Clancy C, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD (2016) Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 62(4):e1–e50
23. Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, Rex JH, Sobel JD, Pappas PG, Kullberg BJ, Mycoses Study Group (2012) Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 54:1110–1122
24. Morrell M, Fraser VJ, Kollef MH (2005) Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005 49(9):3640–3645
25. Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, Bearden DT (2006) Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 43(1):25–31
26. Kludze-Forson M, Eschenauer GA, Kubin CJ, Della-Latta P, Lam SW (2010) The impact of delaying the initiation of appropriate antifungal treatment for Candida bloodstream infection. Med Mycol 48:436–439
27. Hasibeder W, Halabi M (2014) Candida peritonitis. Minerva Anestesiol 80(4):470–481
28. Maseda E, Rodriguez- Manzaneque M, Dominguez D, González-Serrano M, Mouriz L, Álvarez-Escudero J, Ojeda N, Sánchez-Zamora P, Granizo JJ, Giménez MJ, Peri-Operative Infection Working Group of the Spanish Society of Anesthesiology and Critical Care GTIPO-SEDAR (2016) Intraabdominal candidiasis in surgical ICU patients treated with anidulafungin: a multicenter retrospective study. Rev Esp Quimioter 29(1):32–39
29. Solomkin JS, Mazuski JE, Baron EJ, Sawyer RG, Nathens AB, DiPiro JT, Buchman T, Dellinger EP, Jernigan J, Gorbach S, Chow AW, Bartlett J, Infectious Diseases Society of America (2003) Guidelines for the selection of anti-infective agents for complicated intraabdominal infections. Clin Infect Dis 37(8):997–1005
30. Clancy C, Nguyen M (2013) Finding the “missing 50 %” of invasive Candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis 56(9):1284–1292
31. Tissot F, Lamoth F, Hauser PM, Orasch C, Fluckiger U, Siegemund M, Zimmerli S, Calandra T, Bille J, Eggimann P, Marchetti O (2013) Betaglucan antigenemia anticipates diagnosis of blood culture-negative intra-abdominal candidiasis. Am J Respir Crit Care Med 188(9):1100–1109
32. Eggimann P, Que YA, Revelly JP, Pagani JL (2015) Preventing invasive candida infections. where could we do better? J Hosp Infect 89(4):302–308
33. Bassetti M, Leon C, Timsit JF (2015) Are prophylactic antifungals in highly colonized patients safe and effective? Intensive Care Med 41:1336–1339
34. Martínez-Jimenez MC, Muñoz P, Valerio M, Vena A, Guinea J, Bouza E (2015) Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment. J Antimicrob Chemotherap 70(11):3107–3115
35. Azoulay E, Dupont H, Tabah A, Lortholary O, Stahl JP, Francais A, Martin C, Guidet B, Timsit JF (2012) Systemic antifungal therapy in critically ill patients without invasive fungal infection. Crit Care Med 40(3):813–822
36. Ostrosky-Zeichner L (2012) Systemic antifungal therapy in patients without documented invasive fungal infection: a peek into the world of empirical antifungal therapy. Crit Care Med 40(3):997–998
37. Corona A, Colombo R, Ascari A, Raimondi F (2012) Antifungal therapy in the critically ill: in medio stat virtus; is a preemptive approach correct? Crit Care Med 40(9):2737–2738
38. Bailly S, Bouadma L, Azoulay E, Orgeas MG, Adrie C, Souweine B, Schwebel C, Maubon D, Hamidfar-Roy R, Darmon M, Wolff M, Cornet M, Timsit JF (2015) Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients. Am J Respir Crit Care Med 191(10):1139–1146